NCT04710485 is a clinical trial in Brain Meningioma, sponsored by Assiut University.

Who is sponsoring NCT04710485?

NCT04710485 is sponsored by Assiut University.

What condition does NCT04710485 study?

NCT04710485 studies Brain Meningioma.

Is NCT04710485 still recruiting?

NCT04710485 is currently status unknown. Last updated 14 January 2021.

Last reviewed 2021-01-14 · How we verify

NCT04710485

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sphenoorbital Meningioma Management.

Status unknown Last updated 14 January 2021

What this trial tests

trial in Brain Meningioma in 24 participants. Status unknown.

Timeline

30 January 2021

Primary endpoint
20 December 2022

1 January 2023

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	24
Start date	30 January 2021
Primary completion	20 December 2022
Estimated completion	1 January 2023

Conditions studied

Brain Meningioma — all drugs for Brain Meningioma →

Sponsor

Assiut University

Who can join

Adults 5 to 90, any sex, with Brain Meningioma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators will discuss the different surgical techniques for removal of spheno\_orbital meningiomas with proptosis.investigators also will follow up the patient to know the outcome of removal of these tumours.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04710485 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 14 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04710485.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing